PPD News and Press, PPD Inc. From 10/28/21

Image source: The Motley Fool. PPD, Inc. (NASDAQ: PPD) Q3 2021 Earnings Call Oct 28, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: PPD, Inc. (PPD) Q3 2021 Earnings Call Transcript

PPD, Inc. (PPD) Q3 2021 Earnings Conference Call October 28, 2021 08:00 AM ET Company Participants Tracy Krumme - IR David Simmons - CEO Chris Scully - CFO Presentation Operator Hello, and welcome to the PPD Third Quarter 2021 Earnings Call and Webcast. [Operator Instructions] As a reminder, ...

PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, today reported its financial results for the third quarter ended September 30, 2021. Highlights Net authorizations growth of 12.7% over third quarter 2020 to $1,352.7 million, resulting in a net...

PPD, Inc. (Nasdaq: PPD ) was named “Clinical Research Company of the Year” at the 2021 PharmaTimes Clinical Researcher of the Year International competition in London. In addition to PPD winning the highest honor , individual PPD clinical researchers won gold a...

PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will host a conference call on Thursday, October 28, 2021, at 8 a.m. (U.S. Eastern Time) to discuss its third quarter 2021 financial results. Investors and other interested parties may listen to a live webcast of ...

PPD, Inc. (Nasdaq: PPD ) is the recipient of the 2021 Eagle Award from the Society for Clinical Research Sites (SCRS) for its commitment to advancing clinical research professionalism through strong site partnerships. The award, based on voting by research sites globally, recogn...

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs PR Newswire SAN DIEGO , Sept. 30 ,  2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-thre...

PPD, Inc. (Nasdaq: PPD ) has been recognized with two global excellence awards for its effective learning programs, honoring the company’s high-performing employee development initiatives supporting delivery of global operational excellence and innovative solutions to custome...

PPD Inc. (NASDAQ:PPD) traded at a new 52-week high today of $46.93. Approximately 118,000 shares have changed hands today, as compared to an average 30-day volume of 1 million shares. PPD is a global contract research organization that provides clinical trial and laboratory services to p...

PPD Inc. (NASDAQ:PPD) traded today at a new 52-week high of $46.78. So far today approximately 118,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. PPD Inc. (NASDAQ:PPD) is currently priced 53.9% above its average consensus analyst price targ...